YES1 is a druggable oncogenic target in SCLC

dc.contributor.author	Redin, E.
dc.contributor.author	Garrido Martin, E. M.
dc.contributor.author	Valencia, K.
dc.contributor.author	Redrado, M.
dc.contributor.author	Solorzano, J. L.
dc.contributor.author	Carias, R.
dc.contributor.author	Echepare, M.
dc.contributor.author	Exposito, F.
dc.contributor.author	Serrano, D.
dc.contributor.author	Ferrer, I.
dc.contributor.author	Núñez Buiza, A.
dc.contributor.author	Garmendia, I.
dc.contributor.author	García Pedrero, Juana María
dc.contributor.author	Gurpide, A.
dc.contributor.author	Paz Ares, L.
dc.contributor.author	Politi, K.
dc.contributor.author	Montuenga, L. M.
dc.contributor.author	Calvo, A.
dc.date.accessioned	2023-04-25T10:13:35Z
dc.date.available	2023-04-25T10:13:35Z
dc.date.issued	2022
dc.identifier.citation	Journal of Thoracic Oncology, 17(12), p. 1387-1403 (2022); doi:10.1016/j.jtho.2022.08.002
dc.identifier.issn	1556-0864
dc.identifier.uri	http://hdl.handle.net/10651/67673
dc.format.extent	p. 1387-1403
dc.language.iso	eng
dc.relation.ispartof	Journal of Thoracic Oncology
dc.rights	© 2022 International Association for the Study of Lung Cancer. Published by Elsevier Inc.
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138523356&doi=10.1016%2fj.jtho.2022.08.002&partnerID=40&md5=145765e9a06c40f7c249e76d74715921
dc.title	YES1 is a druggable oncogenic target in SCLC
dc.type	journal article
dc.identifier.doi	10.1016/j.jtho.2022.08.002
dc.relation.publisherversion	http://dx.doi.org/10.1016/j.jtho.2022.08.002

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.